Literature DB >> 20039274

RANKL induces heterogeneous DC-STAMP(lo) and DC-STAMP(hi) osteoclast precursors of which the DC-STAMP(lo) precursors are the master fusogens.

Kofi A Mensah1, Christopher T Ritchlin, Edward M Schwarz.   

Abstract

Osteoclasts (OC) are multinucleated bone resorbing cells that form via RANKL-induced fusion of heterogeneous mononuclear OC precursors (OCP). Currently, there are no unique surface markers to distinguish these OCP populations, which are diagnostic for erosive and metabolic bone diseases using culture assays. Thus, we investigated expression of DC-STAMP, a surface receptor required for OCP fusion, during osteoclastogenesis in vitro using a novel monoclonal antibody (1A2). Immunoprecipitation-Western blot analysis of OCP membrane proteins detected 106 kDa dimeric and 53 kDa monomeric DC-STAMP in non-denaturing and denaturing conditions, respectively, with greater sensitivity versus rabbit anti-sera (KR104). 1A2 also detected 99.9% of undifferentiated monocytes as a single population by flow cytometry with a MFI 100-fold over background, while KR104 was not useful in this assay. Functionally, 1A2 inhibited OCP fusion in vitro. RANKL stimulation of OCP induced DC-STAMP(lo) and DC-STAMP(hi) cells, which mature into OC and mononuclear cells respectively as determined by fluorescent microscopy and TRAP assays. Addition of DC-STAMP(hi) cells to purified DC-STAMP(lo) cultures produced larger, more nucleated OC vs. pure DC-STAMP(lo) cultures. RT-qPCR analysis of these two populations showed that OC markers (Trap and Oc-stamp) and fusogenic gene expression (Cd9 and Cd47), were significantly increased in DC-STAMP(lo) vs. DC-STAMP(hi) cells. Collectively, these results demonstrate that DC-STAMP is expressed on OCP as a dimer, which is efficiently detected by 1A2 via flow cytometry. RANKL induces osteoclastogenesis by stimulating DC-STAMP internalization in some OCP, and these DC-STAMP(lo) cells display the "master fusogen" phenotype. In contrast, DC-STAMP(hi) OCP can only act as mononuclear donors. J. Cell. Physiol. 223: 76-83, 2010. (c) 2009 Wiley-Liss, Inc.

Entities:  

Keywords:  Cell Fusion; Dendritic Cell-Specific Transmembrane Protein (DC-STAMP); Osteoclast Precursors (OCP)

Mesh:

Substances:

Year:  2010        PMID: 20039274      PMCID: PMC2814997          DOI: 10.1002/jcp.22012

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  36 in total

1.  Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts.

Authors:  S Takeshita; K Kaji; A Kudo
Journal:  J Bone Miner Res       Date:  2000-08       Impact factor: 6.741

Review 2.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

Review 3.  G protein-coupled receptor dimerization: function and ligand pharmacology.

Authors:  Graeme Milligan
Journal:  Mol Pharmacol       Date:  2004-07       Impact factor: 4.436

Review 4.  Bone resorption by osteoclasts.

Authors:  S L Teitelbaum
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

5.  Two novel genes FIND and LIND differentially expressed in deactivated and Listeria-infected human macrophages.

Authors:  H Staege; A Brauchlin; G Schoedon; A Schaffner
Journal:  Immunogenetics       Date:  2001-03       Impact factor: 2.846

6.  Regulation of receptor activator of NF-kappa B ligand-induced osteoclastogenesis by endogenous interferon-beta (INF-beta ) and suppressors of cytokine signaling (SOCS). The possible counteracting role of SOCSs- in IFN-beta-inhibited osteoclast formation.

Authors:  Toshikichi Hayashi; Toshio Kaneda; Yoshiaki Toyama; Masayoshi Kumegawa; Yoshiyuki Hakeda
Journal:  J Biol Chem       Date:  2002-05-22       Impact factor: 5.157

7.  Two year randomized controlled trial of etidronate in rheumatoid arthritis: changes in serum aminoterminal telopeptides correlate with radiographic progression of disease.

Authors:  Heikki Valleala; Leena Laasonen; Marja-Kaisa Koivula; Jami Mandelin; Claes Friman; Juha Risteli; Yrjö T Konttinen
Journal:  J Rheumatol       Date:  2003-03       Impact factor: 4.666

8.  Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice.

Authors:  Ping Li; Edward M Schwarz; Regis J O'Keefe; Lin Ma; R John Looney; Christopher T Ritchlin; Brendan F Boyce; Lianping Xing
Journal:  Arthritis Rheum       Date:  2004-01

9.  Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis.

Authors:  Christopher T Ritchlin; Sally A Haas-Smith; Ping Li; David G Hicks; Edward M Schwarz
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 10.  Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications.

Authors:  S R Goldring; E M Gravallese
Journal:  Arthritis Res       Date:  1999-12-22
View more
  50 in total

1.  Investigating global gene expression changes in a murine model of cherubism.

Authors:  Tulika Sharma; Justin Cotney; Vijender Singh; Archana Sanjay; Ernst J Reichenberger; Yasuyoshi Ueki; Peter Maye
Journal:  Bone       Date:  2020-03-10       Impact factor: 4.398

2.  Demethoxycucumin protects MDA-MB-231 cells induced bone destruction through JNK and ERK pathways inhibition.

Authors:  Xiaofeng Shen; Xiaochen Sun; Hua Chen; Binjie Lu; Yuanyuan Qin; Chenxi Zhang; Guoqiang Liang; Jiangping Wang; Pengfei Yu; Li Su; Qihan Ma; Yuwei Li
Journal:  Cancer Chemother Pharmacol       Date:  2021-01-05       Impact factor: 3.333

3.  Enoxacin directly inhibits osteoclastogenesis without inducing apoptosis.

Authors:  Edgardo J Toro; Jian Zuo; David A Ostrov; Dana Catalfamo; Vivian Bradaschia-Correa; Victor Arana-Chavez; Aliana R Caridad; John K Neubert; Thomas J Wronski; Shannon M Wallet; L Shannon Holliday
Journal:  J Biol Chem       Date:  2012-04-02       Impact factor: 5.157

4.  Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP).

Authors:  Ya-Hui Chiu; Kofi A Mensah; Edward M Schwarz; Yawen Ju; Masahiko Takahata; Changyong Feng; Loralee A McMahon; David G Hicks; Ben Panepento; Peter C Keng; Christopher T Ritchlin
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

5.  Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease.

Authors:  Jose U Scher; Carles Ubeda; Alejandro Artacho; Mukundan Attur; Sandrine Isaac; Soumya M Reddy; Shoshana Marmon; Andrea Neimann; Samuel Brusca; Tejas Patel; Julia Manasson; Eric G Pamer; Dan R Littman; Steven B Abramson
Journal:  Arthritis Rheumatol       Date:  2015-01       Impact factor: 10.995

6.  Fertilization in C. elegans requires an intact C-terminal RING finger in sperm protein SPE-42.

Authors:  Luke D Wilson; Jacqueline M Sackett; Bryce D Mieczkowski; Abigail L Richie; Kara Thoemke; Jon N Rumbley; Tim L Kroft
Journal:  BMC Dev Biol       Date:  2011-02-23       Impact factor: 1.978

7.  Muscle paralysis induces bone marrow inflammation and predisposition to formation of giant osteoclasts.

Authors:  Brandon J Ausk; Leah E Worton; Kate S Smigiel; Ronald Y Kwon; Steven D Bain; Sundar Srinivasan; Edith M Gardiner; Ted S Gross
Journal:  Am J Physiol Cell Physiol       Date:  2017-08-30       Impact factor: 4.249

Review 8.  Decursin and decursinol angelate: molecular mechanism and therapeutic potential in inflammatory diseases.

Authors:  Adeeb Shehzad; Sajida Parveen; Munibah Qureshi; Fazli Subhan; Young Sup Lee
Journal:  Inflamm Res       Date:  2017-11-13       Impact factor: 4.575

9.  Platelet-derived growth factor BB enhances osteoclast formation and osteoclast precursor cell chemotaxis.

Authors:  Dian-Qi Li; Qi-Long Wan; Janak L Pathak; Zu-Bing Li
Journal:  J Bone Miner Metab       Date:  2016-09-14       Impact factor: 2.626

Review 10.  The molecular complexity of fertilization: Introducing the concept of a fertilization synapse.

Authors:  Amber R Krauchunas; Matthew R Marcello; Andrew Singson
Journal:  Mol Reprod Dev       Date:  2016-04-28       Impact factor: 2.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.